The Washington Research Foundation awarded $387,050 to Derrick Hicks, PhD, at UW’s Institute for Protein Design to advance minibinder-based radiotherapies for cancer. These small, highly specific proteins overcome the limitations of traditional radiolabeled antibodies by better targeting tumors, minimizing damage to healthy cells, and safely exiting the body. The project uses machine learning to streamline development and involves international collaborators.
Washington Research Foundation Awards $387K Grant to Derrick Hicks of the University of Washington’s (UW) Institute for Protein Design
Share: